YU59098A - Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži - Google Patents
Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadržiInfo
- Publication number
- YU59098A YU59098A YU59098A YU59098A YU59098A YU 59098 A YU59098 A YU 59098A YU 59098 A YU59098 A YU 59098A YU 59098 A YU59098 A YU 59098A YU 59098 A YU59098 A YU 59098A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- piperidine derivatives
- substituted spiro
- spiro
- substituted
- emesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Pronalazak se odnosi na supstituisane spiro-piperidin derivate strukturne formule (I): koji su antagonisti receptora tahikinina koji su od koristi, npr. za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije. Pronalazak se takodje odnosi na postupak dobijanja navedenih derivata, njihovu upotrebu u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije, i farmaceutske sastave koji ih sadrže.[Substituted spiro-piperidine derivatives of structural formula (I) are tachykinin receptor antagonists of use, for example, in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9613108.1A GB9613108D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic agents |
GB9625051A GB9625051D0 (en) | 1996-12-02 | 1996-12-02 | Therapeutic agents |
GBGB9626593.9A GB9626593D0 (en) | 1996-12-20 | 1996-12-20 | Therapeutic agents |
GB9701459A GB9701459D0 (en) | 1997-01-24 | 1997-01-24 | Therapeutic agents |
GBGB9710743.7A GB9710743D0 (en) | 1997-05-23 | 1997-05-23 | Therapeutic agents |
GBGB9710748.6A GB9710748D0 (en) | 1997-05-23 | 1997-05-23 | Therapeutic agents |
GBGB9710747.8A GB9710747D0 (en) | 1997-05-23 | 1997-05-23 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
YU59098A true YU59098A (sh) | 2002-06-19 |
Family
ID=27562932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU59098A YU59098A (sh) | 1996-06-21 | 1997-06-17 | Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži |
Country Status (19)
Country | Link |
---|---|
US (1) | US6071927A (sh) |
EP (1) | EP0906315A1 (sh) |
JP (1) | JP2000510153A (sh) |
KR (1) | KR20000022060A (sh) |
AU (1) | AU722541B2 (sh) |
BG (1) | BG102998A (sh) |
BR (1) | BR9709915A (sh) |
CA (1) | CA2257964A1 (sh) |
CZ (1) | CZ424798A3 (sh) |
EA (1) | EA001574B1 (sh) |
EE (1) | EE9800459A (sh) |
IL (1) | IL126900A0 (sh) |
NO (1) | NO985977L (sh) |
NZ (1) | NZ332777A (sh) |
PL (1) | PL330235A1 (sh) |
SK (1) | SK175398A3 (sh) |
TR (1) | TR199802667T2 (sh) |
WO (1) | WO1997049710A1 (sh) |
YU (1) | YU59098A (sh) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1019410A1 (en) * | 1995-11-23 | 2000-07-19 | MERCK SHARP & DOHME LTD. | Spiro-piperidine derivatives and their use as tachykinin antagonists |
US6274604B1 (en) | 1996-07-17 | 2001-08-14 | Merck & Co., Inc. | Alteration of circadian rhythmicity with a tachykinin antagonist |
US5929094A (en) * | 1996-10-25 | 1999-07-27 | Merck & Co., Inc. | Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists |
GB9625843D0 (en) * | 1996-12-12 | 1997-01-29 | Merck & Co Inc | Phenyl spiroethercycloalkyl tachykinn receptor antagonists |
US5977104A (en) * | 1996-12-02 | 1999-11-02 | Merck Sharp & Dohme Ltd. | Use of NK-1 receptor antagonists for treating bipolar disorders |
WO1998024443A1 (en) * | 1996-12-02 | 1998-06-11 | Merck Sharp & Dohme Limited | Use of nk-1 receptor antagonists for treating bipolar disorders |
JP2001524960A (ja) * | 1997-04-24 | 2001-12-04 | メルク シヤープ エンド ドーム リミテツド | 摂食障害を治療するためのnk−1受容体拮抗薬の使用 |
GB9716463D0 (en) * | 1997-08-04 | 1997-10-08 | Merck Sharp & Dohme | Therapeutic agents |
CA2298777A1 (en) * | 1997-08-04 | 1999-02-18 | Merck Sharp & Dohme Limited | Use of nk-1 receptor antagonists for treating mania |
WO1999007375A1 (en) * | 1997-08-04 | 1999-02-18 | Merck Sharp & Dohme Limited | Use of nk-1 receptor antagonists for treating aggressive behaviour disorders |
GB9812662D0 (en) * | 1998-06-11 | 1998-08-12 | Merck Sharp & Dohme | Therapeutic use |
GB9812617D0 (en) * | 1998-06-11 | 1998-08-12 | Merck Sharp & Dohme | Therapeutic use |
GB9816897D0 (en) * | 1998-08-04 | 1998-09-30 | Merck Sharp & Dohme | Therapeutic use |
GB9902881D0 (en) | 1999-02-09 | 1999-03-31 | Merck Sharp & Dohme | Therapeutic agents |
GB0004699D0 (en) | 2000-02-28 | 2000-04-19 | Merck Sharp & Dohme | Chemical synthesis |
US20050042194A1 (en) | 2000-05-11 | 2005-02-24 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
GB0017256D0 (en) | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
DE10040051A1 (de) * | 2000-08-11 | 2002-02-21 | Basf Ag | Derivate des 4-(Trifluormethyl)-phenols sowie Derivate des 4-(Trifluormethylphenyl)-2-(tetrahydropyranyl)ethers und Verfahren zu ihre Herstellung |
US20020103110A1 (en) * | 2001-01-26 | 2002-08-01 | Spitzer A. Robert | System and method for rectal administration of medication for treatment of migraines |
GB0108973D0 (en) * | 2001-04-10 | 2001-05-30 | Merck Sharp & Dohme | Therapeutic agents |
GB0121874D0 (en) * | 2001-09-10 | 2001-10-31 | Merck Sharp & Dohme | Therapeutic agents |
US6673792B1 (en) * | 2002-07-11 | 2004-01-06 | Upchuck, Llc | Broad-spectrum anti-emetic compositions and associated methods |
US7442698B2 (en) | 2003-07-24 | 2008-10-28 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
KR101412339B1 (ko) | 2004-07-15 | 2014-06-25 | 알바니 몰레큘라 리써치, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를차단하기 위한 용도 |
CN101495184A (zh) | 2005-07-15 | 2009-07-29 | Amr科技公司 | 芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用 |
AU2006297443B2 (en) | 2005-09-29 | 2010-08-12 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
EP2083831B1 (en) | 2006-09-22 | 2013-12-25 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
WO2008090117A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1 |
AU2008233662B2 (en) | 2007-04-02 | 2012-08-23 | Msd K.K. | Indoledione derivative |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
CA2760837C (en) | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
US8815894B2 (en) | 2009-05-12 | 2014-08-26 | Bristol-Myers Squibb Company | Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
US9034899B2 (en) | 2009-05-12 | 2015-05-19 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
CN105209436B (zh) | 2013-03-15 | 2019-02-01 | 南洋理工大学 | 3-哌啶酮化合物及其作为神经激肽-1(nk1)受体拮抗剂的用途 |
WO2022015628A2 (en) * | 2020-07-15 | 2022-01-20 | St. Jude Children's Research Hospital, Inc. | Obese ferret model and methods of establishing and using the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU693087B2 (en) * | 1993-01-28 | 1998-06-25 | Merck & Co., Inc. | Spiro-substituted azacycles as tachykinin receptor antagonists |
AU6226494A (en) * | 1993-03-04 | 1994-09-26 | Pfizer Inc. | Spiroazacyclic derivatives as substance p antagonists |
EP0702681A1 (en) * | 1993-06-07 | 1996-03-27 | Merck & Co. Inc. | Spiro-substituted azacycles as neurokinin antagonists |
GB9417956D0 (en) * | 1994-09-02 | 1994-10-26 | Merck Sharp & Dohme | Therapeutic agents |
GB9426103D0 (en) * | 1994-12-23 | 1995-02-22 | Merck Sharp & Dohme | Therapeutic agents |
EP1019410A1 (en) * | 1995-11-23 | 2000-07-19 | MERCK SHARP & DOHME LTD. | Spiro-piperidine derivatives and their use as tachykinin antagonists |
-
1997
- 1997-06-17 WO PCT/GB1997/001630 patent/WO1997049710A1/en not_active Application Discontinuation
- 1997-06-17 AU AU31020/97A patent/AU722541B2/en not_active Ceased
- 1997-06-17 PL PL97330235A patent/PL330235A1/xx unknown
- 1997-06-17 KR KR1019980710463A patent/KR20000022060A/ko not_active Application Discontinuation
- 1997-06-17 TR TR1998/02667T patent/TR199802667T2/xx unknown
- 1997-06-17 CZ CZ984247A patent/CZ424798A3/cs unknown
- 1997-06-17 YU YU59098A patent/YU59098A/sh unknown
- 1997-06-17 IL IL12690097A patent/IL126900A0/xx unknown
- 1997-06-17 EA EA199900045A patent/EA001574B1/ru not_active IP Right Cessation
- 1997-06-17 CA CA002257964A patent/CA2257964A1/en not_active Abandoned
- 1997-06-17 BR BR9709915A patent/BR9709915A/pt unknown
- 1997-06-17 US US09/202,493 patent/US6071927A/en not_active Expired - Fee Related
- 1997-06-17 EE EE9800459A patent/EE9800459A/xx unknown
- 1997-06-17 EP EP97926140A patent/EP0906315A1/en not_active Withdrawn
- 1997-06-17 SK SK1753-98A patent/SK175398A3/sk unknown
- 1997-06-17 NZ NZ332777A patent/NZ332777A/en unknown
- 1997-06-17 JP JP10502496A patent/JP2000510153A/ja not_active Withdrawn
-
1998
- 1998-12-08 BG BG102998A patent/BG102998A/xx unknown
- 1998-12-18 NO NO985977A patent/NO985977L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TR199802667T2 (xx) | 1999-03-22 |
EE9800459A (et) | 1999-06-15 |
EA001574B1 (ru) | 2001-06-25 |
EP0906315A1 (en) | 1999-04-07 |
US6071927A (en) | 2000-06-06 |
AU722541B2 (en) | 2000-08-03 |
EA199900045A1 (ru) | 1999-06-24 |
CZ424798A3 (cs) | 1999-05-12 |
BG102998A (en) | 1999-09-30 |
JP2000510153A (ja) | 2000-08-08 |
IL126900A0 (en) | 1999-09-22 |
NZ332777A (en) | 2000-06-23 |
NO985977D0 (no) | 1998-12-18 |
BR9709915A (pt) | 1999-08-10 |
SK175398A3 (en) | 2000-04-10 |
WO1997049710A1 (en) | 1997-12-31 |
PL330235A1 (en) | 1999-05-10 |
KR20000022060A (ko) | 2000-04-25 |
NO985977L (no) | 1999-02-22 |
AU3102097A (en) | 1998-01-14 |
CA2257964A1 (en) | 1997-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU59098A (sh) | Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži | |
DE69528823D1 (en) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
AU4310097A (en) | Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists | |
TR199801315T2 (xx) | X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�. | |
MX9805255A (es) | Antagonistas de receptor de vitronectina. | |
MY131298A (en) | 5-heteroyl indole derivatives | |
MX9703186A (es) | Antagonistas del receptor del neuropeptido y de indolilo. | |
MY116002A (en) | Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis | |
HUT74992A (en) | Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia | |
PL327934A1 (en) | Novel substituted imidazole compounds | |
SI0725779T1 (sh) | ||
MX9805628A (es) | Imidazoles novedosos substituidos con cicloalquilo. | |
MXPA99001870A (es) | Antagonistas del receptor de taquicinina,no peptidicos. | |
HU9503826D0 (en) | Heterocycles useful as neurokinin antagonists | |
MY115310A (en) | Substance p antagonists for the treatment of emesis | |
WO1993000094A3 (en) | Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine | |
GB9305718D0 (en) | Medicaments | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
BG102589A (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists | |
AU3745795A (en) | Use of CCK-B receptor antagonists for the treatment of sleepdisorders | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
MX9606179A (es) | Agonistas y antagonistas de los receptores del acido acetilcolina nicotinico de insectos para el control de endoparasitos. | |
AU1799297A (en) | Spiro-ketal derivatives and their use as therapeutic agents | |
EP0778833A4 (en) | ENDOTHELIN RECEPTOR ANTAGONISTS | |
ES2163717T3 (es) | Derivados de pirrolidinona y su uso como medicamentos antipsicoticos. |